Navigation Links
Mayo Clinic: Heart patients fare better in 3-year program
Date:6/4/2008

a relationship with the patients and meet face-to-face every three to six months. This follows an initial intensive training period about lifestyle changes and medications. In contrast, aftercare programs often are only a few months long and lack coordination and direct involvement of health care providers who are specifically trained in cardiac rehabilitation, or who rigorously review clinical and lifestyle data.
  • The approach offers clear clinical benefits. At three years, the participants attained and maintained most of the behaviors for preventing subsequent heart attacks. These behaviors are known as secondary heart-attack prevention measures. They include exercising regularly and taking specific heart-protecting medications. Most lowered their cholesterol levels and blood pressure to within recommended levels. Of the 503 participants, compliance with aspirin usage was 91 percent; statin usage, 91 percent; beta-blocker usage, 78 percent; and angiotensin-converting enzyme inhibitor usage, 76 percent.
  • Patients in the disease manager model of care versus traditional care had a lower death rate. While larger studies will need to validate this finding, over the three years of the study, 29 participants died, (25 men and four women), an annual death rate of 1.9 percent. This compares to the Centers for Disease Control and Prevention's expected annual death rate of 1.6 percent for Americans of comparable ages in the general population without heart problems. By comparison, the annual death rate over three years for an additional group of 102 patients who were enrolled in cardiac rehabilitation but who did not receive long-term disease management, was 6.5 percent.
  • Being overweight remains a prevalent and persistent risk factor for heart attack. As measured by body mass index, being overweight was the one heart disease risk factor that did not respond well to this disease manager approach. Other studies also have shown body w
    '/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Study finds link between amphetamine abuse and heart attacks in young adults
2. Low-Salt Diet May Not Be Best for Heart
3. Heart Failure Patients Overestimate Their Life Expectancy
4. VIDEO from Medialink and Abiomed: Worlds Smallest Heart Pump Receives 510(K) Clearance from FDA
5. American Italian Pasta Company Extends Line of Healthier Pastas With Heartland(R) Perfect Balance
6. Members of European Parliament discuss food labeling and heart health
7. Black Athletes Hearts May Differ From Those of Whites
8. Some Fats Deserve Change of Heart
9. Genetic Disorder Drug Helps Reverse Heart Muscle Enlargement
10. Multiple Independent Studies Report on Use of Cylexs Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients
11. American Heart Association Survey Reveals Americans Lack Confidence in Lifesaving Skills for Common Cardiac Emergency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2015)... ... 2015 , ... Doctors in Chicago have published a new study on the ... Mesothelioma has just posted an article on the research on its website. Click ... performed a retrospective analysis of 117 mesothelioma patients who underwent extended pleurectomy between 2008 ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published ... for in nursing homes and assisted living facilities are receiving insufficient care that could ... which her father was at one point close to death, not because of a ...
(Date:9/4/2015)... ... , ... Mile High Connects today releases “First and Last Mile Connections,” a ... bike paths, and other vital supports severely limit access to public transportation for many ... to expand public transit, there’s very little support for safe and convenient access to ...
(Date:9/4/2015)... ... 04, 2015 , ... After wearing the same uniforms for six seasons, the ... an effort to assist the team, the Jones Agency, a locally owned insurance firm ... funds for the new uniforms. , As is so often the case with high ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... now available at CitiDent. CEREC is a newer method for creating restorations through ... for patients by eliminating the need for multiple appointments, CEREC produces restorations with ...
Breaking Medicine News(10 mins):Health News:New Study Appears to Validate the Safety of Mesothelioma Surgery for Older Patients, According to Surviving Mesothelioma 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... Greater access for people with disabilities means more who can keep working, ... ... July 24, 2008 -- With the signing of the Americans with Disabilities ... of people with disabilities and their families. In 18 years, thousands of ...
... cleanroom manufacturing company has introduced a new product feature for its ... be integrated into the cleanroom system and enhance the cleanroom appearance. ... ... Gerbig Engineering, a designer, fabricator and installer of cleanroom systems, announced ...
... As America's baby boomers age, more and more are developing dangerous ... ID tags. Lauren's Hope medical alert bracelet jewelry gives a generation ... ... (PRWEB) July 24, 2008 -- Baby boomers with potentially life-threatening health ...
... the Financing Needs of European and ... Companies and Institutions--, NEW YORK, July 24 Paul ... to Partner. Based in Paul,Capital,s London office, Dr. Macleod is ... for the Paul Capital Healthcare funds., "Since he joined ...
... relations ... physicians, SOUTH BEND, Ind., July 24 Press ... Hospitals,finds that there continues to be a gap in ... to be more,responsive to the ideas and needs of ...
... WINSTON-SALEM, N.C. A study out of Wake Forest ... correctly identifying patients who are having a heart attack, ... The study used data from a registry called i*trACS, ... admitted to emergency departments (EDs) in eight participating U.S. ...
Cached Medicine News:Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 2Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:Authoritative Report on Physician Perspectives Released Today 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
... The ESR-10 Manual Rack is a ... determining the erythrocyte sedimentation rate (ESR) ... using 1.2ml Streck ESR-Vacuum Tubes. The ... tubes simultaneously. The ESR-10 Manual Rack ...
... Streck Cytometry Concentrate is for use as ... flow cytometry. Each 70ml bottle of Cytometry ... with distilled water. Compared to Cubitainers, Streck ... space and saves money without compromising performance. ...
Medicine Products: